Frontiers in Immunology | Cancer Immunity and Immunotherapy

Review

Published on 12 Aug 2024

Minimal residual disease detection in lymphoma: methods, procedures and clinical significance

in Cancer Immunity and Immunotherapy

Sijun Zhang
Xiangyu Wang
Zhenzhen Yang
Mengjie Ding
Mingzhi Zhang
Ken H. Young
Xudong Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1430070

2,614 views

Review

Published on 09 Aug 2024

Master regulator: p53’s pivotal role in steering NK-cell tumor patrol

in Cancer Immunity and Immunotherapy

Haohao Wang
Qingjie Chen
Qinghua Liu
Changjiang Luo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1428653

2,668 views
1 citation

Systematic Review

Published on 09 Aug 2024

Efficacy and safety of lenvatinib plus pembrolizumab in patients with advanced and recurrent endometrial cancer: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Guangwei Yan
Yanmin Du
Huanhuan Zhang
Jinxiang Yan
Yixuan Liu
Zhenying Ban
Yong-Zhen Guo
Xianxu Zeng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1404669

2,383 views

Original Research

Published on 09 Aug 2024

The relationship between metabolite mediated immune regulatory imbalance and the occurrence of malignant tumors of bone and articular cartilage: a Mendelian randomization study

in Cancer Immunity and Immunotherapy

Kehan Long
Ao Gong
Tengfei Zheng
Shoushen Liu
Zhendong Ying
Cong Xiao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1433219

2,007 views
1 citation

Review

Published on 09 Aug 2024

Nanomaterials: leading immunogenic cell death-based cancer therapies

in Cancer Immunity and Immunotherapy

Changyu Ma
Zhe Cheng
Haotian Tan
Yihan Wang
Shuzhan Sun
Mingxiao Zhang
Jianfeng Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1447817

2,509 views
2 citations

Review

Published on 09 Aug 2024

Progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Tong Liu
Guorui Meng
Shihui Ma
Junqi You
Liang Yu
Risheng He
Xudong Zhao
Yunfu Cui

Frontiers in Immunology

doi 10.3389/fimmu.2024.1455716

2,148 views

Original Research

Published on 09 Aug 2024

Investigating the impact of STING pathway activation on breast cancer treatment outcomes: development and validation of a prognostic model

in Cancer Immunity and Immunotherapy

YangYan Zhong
Hong Cao
Wei Li
Jian Deng
Dan Li
JunJie Deng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1438364

2,818 views

Review

Published on 08 Aug 2024

Cannabinoids and triple-negative breast cancer treatment

in Cancer Immunity and Immunotherapy

Luka Dobovišek
Simona Borštnar
Nataša Debeljak
Simona Kranjc Brezar

Frontiers in Immunology

doi 10.3389/fimmu.2024.1386548

6,310 views
3 citations

Original Research

Published on 08 Aug 2024

In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigens

in Cancer Immunity and Immunotherapy

Silvia Brugiapaglia
Sara Bulfamante
Claudia Curcio
Maddalena Arigoni
Raffaele Calogero
Lisa Bonello
Elisa Genuardi
Rosella Spadi
Maria Antonietta Satolli
Donata Campra

Frontiers in Immunology

doi 10.3389/fimmu.2024.1427424

1,817 views
1 citation

Original Research

Published on 08 Aug 2024

Multi-transcriptomics analysis of microvascular invasion-related malignant cells and development of a machine learning-based prognostic model in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Haoran Huang
Feifeng Wu
Yang Yu
Borui Xu
Dehua Chen
Yuwei Huo
Shaoqiang Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1436131

4,701 views
1 citation

Original Research

Published on 08 Aug 2024

Potentially functional variants of INPP5D and EXOSC3 in immunity B cell-related genes are associated with non-small cell lung cancer survival

in Cancer Immunity and Immunotherapy

Guojun Lu
Hongliang Liu
Huilin Wang
Xiaozhun Tang
Sheng Luo
Mulong Du
David C. Christiani
Qingyi Wei

Frontiers in Immunology

doi 10.3389/fimmu.2024.1440454

1,914 views

Original Research

Published on 08 Aug 2024

Multi-omics pan-cancer analysis reveals the prognostic values and immunological functions of PPA2, with a spotlight on breast cancer

in Cancer Immunity and Immunotherapy

Jia-Ning Zhang
Bei-Bei Yang
Lin-Wei Li
Hao Xu
Bin Wang
Zi-Lu Yi
Xi-Rui Zhou
Hong Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1435502

2,334 views

Original Research

Published on 07 Aug 2024

Tumor necrosis factor inhibitors enhance corticosteroid therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis linked to immune checkpoint inhibitors: a prospective study

in Cancer Immunity and Immunotherapy

Chun-Xia He
Lan Guo
Tao Qu
Hong-Zhong Jin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1421684

2,033 views

Review

Published on 07 Aug 2024

Role of tumor-associated macrophages in hepatocellular carcinoma: impact, mechanism, and therapy

in Cancer Immunity and Immunotherapy

Yinqi Zhang
Guoyong Han
Jian Gu
Zhiqiang Chen
Jindao Wu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1429812

2,895 views
5 citations

Original Research

Published on 07 Aug 2024

Establishment of a chemokine-based prognostic model and identification of CXCL10+ M1 macrophages as predictors of neoadjuvant therapy efficacy in colorectal cancer

in Cancer Immunity and Immunotherapy

Abudumaimaitijiang Tuersun
Jianting Huo
Zeping Lv
Yuchen Zhang
Fangqian Chen
Jingkun Zhao
Wenqing Feng
Zhuoqing Xu
Zhihai Mao
Pei Xue

Frontiers in Immunology

doi 10.3389/fimmu.2024.1400722

2,570 views
1 citation

Case Report

Published on 07 Aug 2024

Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic NSCLC

in Cancer Immunity and Immunotherapy

Nicolas Roussot
Marion Thibaudin
Jean-David Fumet
Susy Daumoine
Léa Hampe
Cédric Rébé
Emeric Limagne
Aurélie Lagrange
Victor Herreros
Julie Lecuelle

Frontiers in Immunology

doi 10.3389/fimmu.2024.1437961

1,723 views

Navigation group

Articles

Minimal residual disease detection in lymphoma: methods, procedures and clinical significance

Master regulator: p53’s pivotal role in steering NK-cell tumor patrol

Efficacy and safety of lenvatinib plus pembrolizumab in patients with advanced and recurrent endometrial cancer: a systematic review and meta-analysis

The relationship between metabolite mediated immune regulatory imbalance and the occurrence of malignant tumors of bone and articular cartilage: a Mendelian randomization study

Nanomaterials: leading immunogenic cell death-based cancer therapies

Progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma

Investigating the impact of STING pathway activation on breast cancer treatment outcomes: development and validation of a prognostic model

Cannabinoids and triple-negative breast cancer treatment

In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigens

Multi-transcriptomics analysis of microvascular invasion-related malignant cells and development of a machine learning-based prognostic model in hepatocellular carcinoma

Potentially functional variants of INPP5D and EXOSC3 in immunity B cell-related genes are associated with non-small cell lung cancer survival

Multi-omics pan-cancer analysis reveals the prognostic values and immunological functions of PPA2, with a spotlight on breast cancer

Tumor necrosis factor inhibitors enhance corticosteroid therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis linked to immune checkpoint inhibitors: a prospective study

Role of tumor-associated macrophages in hepatocellular carcinoma: impact, mechanism, and therapy

Establishment of a chemokine-based prognostic model and identification of CXCL10+ M1 macrophages as predictors of neoadjuvant therapy efficacy in colorectal cancer

Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic NSCLC